Teva Proposes to Acquire Mylan for $82.00 Per Share in Cash and Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Stifel Downgrades Perrigo Co. (PRGO) to Hold
April 21, 2015 1:34 PM EDTStifel downgraded Perrigo Co. (NYSE: PRGO) from Buy to Hold.
For an analyst ratings summary and ratings history on Perrigo Co. click here. For more ratings news on Perrigo Co. click here.
Shares of Perrigo Co. closed at $198.08 yesterday.
... MoreBMO Capital Upgrades Mylan (MYL) to Market Perform
April 21, 2015 12:52 PM EDTBMO Capital upgraded Mylan (NASDAQ: MYL) from Underperform to Market Perform with a price target of $75.00 (from $41.00).
For an analyst ratings summary and ratings history on Mylan click here. For more ratings news on Mylan click here.
Shares of Mylan closed at $68.05 yesterday.
... MoreTeva Pharma (TEVA) Needs to Raise Mylan (MYL) Bid to $85-$88/Share, Leerink Partners Says
April 21, 2015 12:10 PM EDTLeerink Partners analyst Jason Gerberry weighed on Teva Pharma (NYSE: TEVA) after the company announced an unsolicited $82/share offer for Mylan (NASDAQ: MYL). The analyst said Teva will likely have to raise its bid to $85-$88 share and even that might not get it done. The analyst said while the deal makes sense, hostile deals carry a low success rate. Despite the comments, the firm... More
Teva Pharma (TEVA) Offers $82/Share for Mylan (MYL)
April 21, 2015 8:46 AM EDTTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced a proposal to acquire all of the outstanding shares of Mylan N.V. (Nasdaq: MYL) in a transaction valued at $82.00 per Mylan share, with the consideration to be comprised of approximately 50 percent cash and 50 percent stock. The Teva cash and stock proposal provides Mylan stockholders with a substantial premium and immediate cash value, as well as significant potential for future value creation through participation in a financially and commercially stronger company.
Tevas proposal also provides Mylan stockholders with a more... More
